These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22825646)

  • 1. HCV coinfection possibly promotes left ventricular dysfunction development: analysis of brain natriuretic peptide serum levels in HCV/HIV-coinfected and HIV-monoinfected patients.
    Dabrowska MM; Mikula T; Wiercinska-Drapalo A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1308-12. PubMed ID: 22825646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
    Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
    Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients.
    Suárez-Zarracina T; Valle-Garay E; Collazos J; Montes AH; Cárcaba V; Carton JA; Asensi V
    J Viral Hepat; 2012 Oct; 19(10):685-93. PubMed ID: 22967099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low plasma levels of dehydroepiandrosterone sulphate in HIV-positive patients coinfected with hepatitis C virus.
    Mauboussin JM; Mahamat A; Peyrière H; Rouanet I; Fabbro-Peray P; Daures JP; Vincent D
    HIV Med; 2004 May; 5(3):151-7. PubMed ID: 15139980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
    Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
    Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis.
    Mederacke I; Potthoff A; Meyer-Olson D; Meier M; Raupach R; Manns MP; Wedemeyer H; Tillmann HL
    J Clin Virol; 2012 Feb; 53(2):110-5. PubMed ID: 22177274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.
    Roe B; Coughlan S; Hassan J; Grogan A; Farrell G; Norris S; Bergin C; Hall WW
    J Infect Dis; 2007 Oct; 196(7):1053-7. PubMed ID: 17763328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of serum markers of liver inflammation and fibrosis in patients with chronic hepatitis C virus infection according to HIV status and antiretroviral use.
    Connoy A; Turner J; Núñez M
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):719-25. PubMed ID: 21128862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.
    Berger A; von Depka Prondzinski M; Doerr HW; Rabenau H; Weber B
    J Med Virol; 1996 Apr; 48(4):339-43. PubMed ID: 8699166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients.
    Trimoulet P; Belzunce C; Faure M; Wittkop L; Reigadas S; Dupon M; Ragnaud JM; Fleury H; Neau D
    HIV Med; 2011 Sep; 12(8):506-9. PubMed ID: 21410862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection.
    Keiserman DR; Both CT; Mattos AA; Remiao J; Alexandre CO; Sherman KE
    Am J Gastroenterol; 2003 Apr; 98(4):878-83. PubMed ID: 12738471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5-year follow-up study.
    Kristoffersen US; Lebech AM; Gerstoft J; Hesse B; Petersen CL; Gutte H; Kjaer A
    HIV Med; 2008 Mar; 9(3):180-6. PubMed ID: 18218002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes.
    Agwale SM; Tanimoto L; Womack C; Odama L; Leung K; Duey D; Negedu-Momoh R; Audu I; Mohammed SB; Inyang U; Graham B; Ziermann R
    J Clin Virol; 2004 Dec; 31 Suppl 1():S3-6. PubMed ID: 15567088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry.
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Clin Trials; 2018 Dec; 19(6):225-234. PubMed ID: 30890063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
    Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
    Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.